NewslettersExtracellular Matrix NewsPulmonary Cell NewsAston University Researchers Collaborate with Biotechnology Start-Up to Develop Drugs to Tackle Irreversible Lung DiseaseBy Bob - January 26, 20230149Aston University announced that they are working with start-up company, Isterian Biotech, part of Cambrian BioPharma, to develop novel drugs to treat fibrotic diseases such as lung disease.[Aston University]Press Release